Induction chemotherapy with docetaxel and cisplatin is highly effective for locally advanced nasopharyngeal carcinoma

Oral Oncology

Volumn 47, Issue 7, 2011, Pages 660-664

  Ekenel, Meltem ^a   Keskin, Serkan ^a   Basaran, Mert ^a   Ozdemir, Canan ^a   Meral, Rasim ^a   Altun, Musa ^a   Aslan, Ismet ^b   Bavbek, Sevil E ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Cisplatin; Docetaxel; Induction chemotherapy; Locally advanced; Nasopharyngeal carcinoma

Indexed keywords

CISPLATIN; DOCETAXEL;

ADULT; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CHEMOTHERAPY INDUCED EMESIS; DERMATITIS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FATALITY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ESOPHAGITIS; FEMALE; HUMAN; LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT RESPONSE; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TAXOIDS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79959768686     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2011.04.010     Document Type: Article

References (22)

1. A.T. Chan , S.F. Leung , R.K. Ngan , P.M. Teo , W.H. Lau , and W.H. Kwan Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma J Natl Cancer Inst 97 7 2005 536 539 (Pubitemid 40590436)
2. M. Al-Sarraf , M. LeBlanc , P.G. Giri , K.K. Fu , J. Cooper , and T. Vuong Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099 J Clin Oncol 16 4 1998 1310 1317 (Pubitemid 28175745)
3. D.T. Chua , J. Ma , J.S. Sham , H.Q. Mai , D.T. Choy , and M.H. Hong Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials J Clin Oncol 23 6 2005 1118 1124 (Pubitemid 46202267)
4. J.A. Langendijk , C.R. Leemans , J. Buter , J. Berkhof , and B.J. Slotman The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature J Clin Oncol 22 22 2004 4604 4612 (Pubitemid 41185128)
5. B. Baujat , H. Audry , J. Bourhis , A.T. Chan , H. Onat , and D.T. Chua Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients Int J Radiat Oncol Biol Phys 64 1 2006 47 56 (Pubitemid 41831208)
6. S. Zenda , Y. Onozawa , N. Boku , Y. Iida , M. Ebihara , and T. Onitsuka Single-agent docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN) Jpn J Clin Oncol 37 7 2007 477 481 (Pubitemid 47335464)
7. D.T. Chua , J.S. Sham , and G.K. Au A phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinoma Oral Oncol 41 6 2005 589 595 (Pubitemid 40828875)
8. J. Zheng , G. Wang , G.Y. Yang , D. Wang , X. Luo , and C. Chen Induction chemotherapy with nedaplatin with 5-FU followed by intensity-modulated radiotherapy concurrent with chemotherapy for locoregionally advanced nasopharyngeal carcinoma Jpn J Clin Oncol 40 5 2010 425 431
9. J.L. Oh , E.E. Vokes , M.S. Kies , B.B. Mittal , M.E. Witt , and R.R. Weichselbaum Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer Ann Oncol 14 4 2003 564 569 (Pubitemid 41295084)
10. D. Ferrari , F. Chiesa , C. Codeca , L. Calabrese , B.A. Jereczek-Fossa , and D. Alterio Locoregionally advanced nasopharyngeal carcinoma: induction chemotherapy with cisplatin and 5-fluorouracil followed by radiotherapy and concurrent cisplatin: a phase II study Oncology 74 3-4 2008 158 166
11. F.M. Johnson , A. Garden , J.L. Palmer , M. Kies , G. Clayman , and B. Brumfield A phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N status Cancer 100 5 2004 991 998 (Pubitemid 38222860)
12. E. Mostafa , M.N. Nasar , N.A. Rabie , S.A. Ibrahim , H.M. Barakat , and A.N. Rabie Induction chemotherapy with paclitaxel and cisplatin, followed by concomitant cisplatin and radiotherapy for the treatment of locally advanced nasopharyngeal carcinoma J Egypt Natl Canc Inst 18 4 2006 348 356
13. M. Airoldi , A.M. Gabriele , M. Garzaro , L. Raimondo , C. Condello , and F. Beatrice Induction chemotherapy with cisplatin and epirubicin followed by radiotherapy and concurrent cisplatin in locally advanced nasopharyngeal carcinoma observed in a non-endemic population Radiother Oncol 92 1 2009 105 110
14. W.K. Bae , J.E. Hwang , H.J. Shim , S.H. Cho , J.K. Lee , and S.C. Lim Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer Cancer Chemother Pharmacol 65 3 2010 589 595
15. G. Fountzilas , C. Tolis , A. Kalogera-Fountzila , C. Karanikiotis , M. Bai , and D. Misailidou Induction chemotherapy with cisplatin, epirubicin, and paclitaxel (CEP), followed by concomitant radiotherapy and weekly paclitaxel for the management of locally advanced nasopharyngeal carcinoma. A Hellenic Cooperative Oncology Group phase II study Strahlenther Onkol 181 4 2005 223 230 (Pubitemid 40585541)
16. X. Lu , X. Guo , M.H. Hong , Q.Y. Chen , Q. Zeng , and Y.Q. Xiang Comparison of the short-term efficacy of two inductive chemotherapy regimens for locally advanced nasopharyngeal caricinoma: docetaxal plus carboplatin versus 5-fluorouracil plus carboplatin Chin J Cancer 29 2 2010 140 144
17. E.P. Hui , B.B. Ma , S.F. Leung , A.D. King , F. Mo , and M.K. Kam Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma J Clin Oncol 27 2 2009 242 249
18. N. Lee , P. Xia , J.M. Quivey , K. Sultanem , I. Poon , and C. Akazawa Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience Int J Radiat Oncol Biol Phys 53 1 2002 12 22 (Pubitemid 34465802)
19. S.L. Wolden , W.C. Chen , D.G. Pfister , D.H. Kraus , S.L. Berry , and M.J. Zelefsky Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience Int J Radiat Oncol Biol Phys 64 1 2006 57 62 (Pubitemid 41831209)
20. N. Lee , J. Harris , A.S. Garden , W. Straube , B. Glisson , and P. Xia Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225 J Clin Oncol 27 22 2009 3684 3690
21. K. Kim , H.G. Wu , H.J. Kim , M.W. Sung , K.H. Kim , and S.H. Lee Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma Head Neck 31 9 2009 1121 1128
22. www.clinicaltrials.gov.